CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops a novel platform using engineered viruses to target therapy-resistant brain tumor cells. It aims to provide a prognostic tool and a suicide gene therapy that can help predict and eliminate cells responsible for tumor relapse, enhancing treatment outcomes for patients with malignant brain tumors.
Emergence of therapy resistance is a major cause of death following conventional chemotherapy and radiation for children and adults with malignant brain tumors.
It is imperative to find novel options to target therapy-resistant brain tumor populations to save lives.
We propose a novel platform providing a prognostic tool and a suicide gene therapy tool using engineered viruses.
It involves targeting freshly biopsied cells from brain tumor patients with our strategy in combination with standard t…
UPPSALA UNIVERSITET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
UPPSALA UNIVERSITET RESEARCHINTELLECTUAL PROPERTY AB
Sweden, Uppsala
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
